SCHEMBL8285170

SCHEMBL8285170

Cc1c(F)cnc2c1c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.46
GSK3B P49841 4/20 0.39
CDK4 P11802 1/20 0.39
CCND1 P24385 1/20 0.39
CCND2 P30279 1/20 0.39
CCND3 P30281 1/20 0.39
GAA P10253 4/20 0.39
HPGD P15428 2/20 0.39
MAPK1 P28482 2/20 0.39
ALDH1A1 P00352 2/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
WEE1 P30291 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
CYP1A2 P05177 3/20 0.35
CYP3A4 P08684 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8285162 0.85 PDE11A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285209 0.84 PDE11A (0.43) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285192 0.84 PDE11A (0.42) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285168 0.84 PDE11A (0.42) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8285222 0.81 PDE11A (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8286060 0.81 PDE11A (0.46) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8286065 0.81 PDE11A (0.46) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL8287158 0.80 PDE11A (0.41) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5872390 0.80 PDE11A (0.45) PDE11AGSK3BCDK4CCND1CCND2
SCHEMBL5871658 0.80 PDE11A (0.48) PDE11AGSK3BCDK4CCND1CCND2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed